Global trends in metabolic-associated hepatocellular carcinoma: genetic and socio-demographic drivers.

doi:10.1007/s12072-026-11107-2

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Global trends in metabolic-associated hepatocellular carcinoma: genetic and socio-demographic drivers.

Hepatology international - 1 Aug 2026

Wu Na, Xiong Xinying, Wang Xinyue, Wei Shuang, Shi Xinyu, Chen Yilin, Zhou Wenjun, Wang Jianying, Zhang Lei, Liu Baocheng, Song Hualing, Yu Huiting, Ji Guang

Abstract excerpt

BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a primary driver of hepatocellular carcinoma (HCC). However, the synergistic impact of ancestral genetic susceptibility and socio-demographic transitions on the global MASLD-HCC landscape remains insufficiently quantified. METHODS: Using GBD 2021 data, we analyzed MASLD-HCC mortality and DALYs across 204 countries...

Read the complete abstract on PubMed